Hi, what are you looking for?
BlueMatrix, a leading provider of capital markets content publishing technology backed by Thoma Bravo, has announced a strategic partnership with Perplexity to enhance AI-enabled...
Owkin launches AI agents for drug discovery, achieving a 23.7% improvement in classification accuracy while utilizing real patient data from over 800 hospitals.